The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
about
ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade GliomasMMP-9 in translation: from molecule to brain physiology, pathology, and therapy.MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1.miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma.Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.
P2860
Q37286187-D22D4323-A6D8-45C4-9044-39CD65FFD247Q38622769-A1DB6320-62EC-4B7A-A0A4-6944FF99ACF5Q38783222-98CE8BEC-239C-4DEB-B032-AC60DD0960A0Q38809332-E88F48F6-7485-446F-B8E6-E6330FCDA85EQ38812076-2C05B5E8-6805-482D-B82E-876F1C45EFE1Q38816564-2E0075BA-204B-4BDE-BF36-397D51CD82F3Q38817536-8CB376D9-41AA-4DE0-B52C-BC8132D9E09CQ38817924-70A377C3-FDEB-4AB8-BC10-24AC51AD1E27Q38819854-86218BE5-83AC-4D91-AD7C-C7C29190EB44Q41093681-7457CC76-0008-430E-B211-75AC5E8DAA85Q48590220-14177A1B-AFAA-4E84-8D62-9A42DF4B8796Q52142503-21361451-DF2F-4F6D-ADED-5131FC92742F
P2860
The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@en
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@nl
type
label
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@en
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@nl
prefLabel
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@en
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@nl
P2093
P2860
P31
P1476
The Clinical Utility of Matrix ...... oma Patients: A Meta-Analysis.
@en
P2093
Daotang Li
Jianzhen Fan
Ranran Shi
Shunzeng Lv
Xiangshan Yang
Yuting Liu
Zhenyu Tang
Zhongfa Xu
P2860
P2888
P356
10.1007/S12035-014-8850-2
P577
2014-08-10T00:00:00Z